Literature DB >> 2253693

Theophylline concentration in the extracellular space of the rat brain: measurement by microdialysis and relation to behaviour.

L Ståhle1, S Segersvärd, U Ungerstedt.   

Abstract

The free extracellular concentration of theophylline in the brain was estimated from microdialysis samples. Two different methods were used to estimate extracellular concentrations by microdialysis, the perfusion rate method and the difference method. Theophylline 20 mg/kg (s.c.) gave a sufficiently stable level of theophylline in the brain 60 min after injection and lasting over the observation period to allow application of the two methods in vivo. The relation between dose and dialysate concentration was linear. It was found that doses of 20-24 mg/kg theophylline corresponded to a free extracellular concentration of 60-90 microM. The behaviour of theophylline-treated rats was assessed in parallel experiments by means of a holeboard apparatus. Behavioural activation was observed in the dose-range 3-30 mg/kg. It is concluded that behavioural effects of theophylline can be induced at a concentration well below that required to inhibit phosphodiesterase but within the range in which adenosine receptor blockade may be observed, suggesting that the latter mechanism is responsible for the behavioural effects of theophylline.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2253693     DOI: 10.1016/0014-2999(90)90639-n

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

1.  Pharmacokinetic estimations from microdialysis data.

Authors:  L Ståhle
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  Application of microdialysis in pharmacokinetic studies.

Authors:  W F Elmquist; R J Sawchuk
Journal:  Pharm Res       Date:  1997-03       Impact factor: 4.200

3.  The use of microdialysis for the study of drug kinetics: some methodological considerations illustrated with antipyrine in rat frontal cortex.

Authors:  P N Patsalos; W T Abed; M S Alavijeh; M T O'Connell
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

4.  Microdialysis sampling to determine the pharmacokinetics of unbound SDZ ICM 567 in blood and brain in awake, freely-moving rats.

Authors:  M J Alonso; A Bruelisauer; P Misslin; M Lemaire
Journal:  Pharm Res       Date:  1995-02       Impact factor: 4.200

5.  Pharmacokinetics and distribution over the blood-brain barrier of zalcitabine (2',3'-dideoxycytidine) and BEA005 (2', 3'-dideoxy-3'-hydroxymethylcytidine) in rats, studied by microdialysis.

Authors:  N Borg; L Ståhle
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

6.  Pharmacokinetics and distribution over the blood brain barrier of two acyclic guanosine analogs in rats, studied by microdialysis.

Authors:  L Ståhle; B Oberg
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

7.  Microdialysis calibration using retrodialysis and zero-net flux: application to a study of the distribution of zidovudine to rabbit cerebrospinal fluid and thalamus.

Authors:  Y Wang; S L Wong; R J Sawchuk
Journal:  Pharm Res       Date:  1993-10       Impact factor: 4.200

8.  Microdialysis in pharmacokinetics.

Authors:  L Ståhle
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1993 Jan-Mar       Impact factor: 2.441

Review 9.  Microdialysis as an Important Technique in Systems Pharmacology-a Historical and Methodological Review.

Authors:  Margareta Hammarlund-Udenaes
Journal:  AAPS J       Date:  2017-07-31       Impact factor: 4.009

10.  Penetration of adenosine antagonists into mouse brain as determined by ex vivo binding.

Authors:  J Baumgold; O Nikodijevic; K A Jacobson
Journal:  Biochem Pharmacol       Date:  1992-02-18       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.